Macular Degeneration News and Research

Latest Macular Degeneration News and Research

Buck researchers identify new, potential drug targets for sporadic PD

Research at the Buck Institute shows the same mechanisms that lead to neuronal cell death in mice genetically fated to develop Parkinson's disease (PD) are involved in the much more common sporadic form of the age-related, neurodegenerative disorder that robs people of the ability to move normally.

2 Jun 2016

Small drug-like molecule that alters perception of food may hold key to extending human healthspan

Researchers at the Buck Institute have shown a new effect on aging via a small drug-like molecule that alters the perception of food in the nematode C. elegans. Publishing in Aging Cell, researchers "tricked" the worm's metabolism into a state of caloric restriction, extending the animal's lifespan by 50 percent.

27 May 2016

Vision Express advises Britons to be 'sun safe' when choosing eyewear

Britons are putting their sight at risk – potentially exposing themselves to cataracts and macular degeneration – by choosing vanity over UV protection when buying sunglasses, new research from Vision Express has revealed.

From Vision Express 26 May 2016

NIH-funded study finds visual impairment, blindness may double by 2050

With the youngest of the baby boomers hitting 65 by 2029, the number of people with visual impairment or blindness in the United States is expected to double to more than 8 million by 2050, according to projections based on the most recent census data and from studies funded by the National Eye Institute, part of the National Institutes of Health.

23 May 2016

LALES study analyzes risk, prevalence of early and late stage AMD among Latinos

The University of Southern California Roski Eye Institute researchers and clinicians published results of the largest population-based study of adult Latinos and age-related macular degeneration (AMD) in the National Eye Institute-funded "Los Angeles Latino Eye Study." The study, published in JAMA Ophthalmology, is the first to analyze the risk and prevalence of early and late stage AMD and its impact on quality of life for older Latinos.

4 May 2016

Report: Protecting eyes from UV exposure not high priority for Americans

Three-quarters of Americans are concerned about potential eye problems from the sun's ultraviolet rays, yet only 31 percent protect their eyes with sunglasses or other UV-protective eyewear every time they go outside, according to a new nationwide survey released today. The report by The Vision Council, based on a survey of more than 10,000 adults, finds 34 percent of adults have experienced symptoms of prolonged UV exposure, such as eye irritation, trouble seeing, and red or swollen eyes.

4 May 2016

Researchers safely transplant stem cells from patient's skin to the eye to restore vision

Researchers have safely transplanted stem cells derived from a patient's skin to the back of the eye in an effort to restore vision. The research is being presented at the 2016 Annual Meeting of the Association for Research in Vision and Ophthalmology this week in Seattle, Wash.

4 May 2016

Artificial and natural vision successfully integrated for first time in humans

Scientists have successfully implanted a prosthesis that restores some central vision in patients with only limited peripheral vision remaining to them - the first time artificial and natural vision has ever been integrated in humans. The research is being presented at the 2016 Annual Meeting of the Association for Research in Vision and Ophthalmology this week in Seattle, Wash.

4 May 2016

NEI-funded study analyzes outcomes of anti-VEGF therapy for AMD

In a study of nearly 650 people with the eye disease age-related macular degeneration (AMD), half still had vision 20/40 or better, typically good enough to drive or to read standard print, after five years of treatment with anti-VEGF drugs that are injected into the eye. The authors of the study, funded by the National Eye Institute (NEI) at the National Institutes of Health, say those outcomes would have been unimaginable about 10 years ago, prior to the drugs' availability.

3 May 2016

NEI to discuss research advances in regenerative medicine for eye disease at ARVO 2016

The National Eye Institute (NEI), part of NIH, is participating in the Inaugural Press Conference from the Association for Research in Vision and Ophthalmology Annual Meeting (ARVO 2016), the largest gathering of eye and vision researchers in the world, attracting over 11,000 attendees from more than 75 countries.

2 May 2016

Scientists find way to reduce need for secondary cataract surgery

Scientists at the University of East Anglia may have found a way to prevent complications from surgery to treat cataract - the world's leading cause of blindness.

29 Apr 2016

Pioneering gene therapy may lead to potential cure for common causes of vision loss

Pioneering gene therapy has restored some vision to patients with a rare form of genetic blindness for as long as four years, raising hopes it could be used to cure common causes of vision loss, new University of Oxford research published today shows.

29 Apr 2016

Exposure to blue light may lead to eyestrain but does not damage retina

Nearly 90 percent of adults use digital devices for two or more hours per day, according to The Vision Council's 2016 Digital Eye Strain Report, exposing consumers to blue light that some suggest is dangerous.

26 Apr 2016

University’s blindness therapy comes a step closer following landmark licensing deal with US firm

Hundreds of thousands of people worldwide, who have a disease that can lead to blindness, could have their sight restored after The University of Manchester entered into a technology license with Seattle-based company Acucela Inc.

13 Apr 2016

University's blindness therapy comes a step closer following landmark licensing deal with US firm

13 Apr 2016

Increased expression of VEGF-A promotes three common aging-related eye conditions

A Massachusetts General Hospital investigator has found that increased expression of the angiogenic factor VEGF-A promotes three common aging-related eye conditions - both versions of age-related macular degeneration (AMD) and also cataracts - in an animal model.

12 Apr 2016

Daily walnut consumption positively impacts blood cholesterol levels in older adults

Initial findings from the Walnuts and Healthy Aging study presented at Experimental Biology 2016 (EB) indicate that daily walnut consumption positively impacts blood cholesterol levels without adverse effects on body weight among older adults.

4 Apr 2016

Leading entrepreneurs, innovators to take part in Royal Society of Medicine's 12th Medical Innovations Summit

A group of leading entrepreneurs and innovators will be gathering at the Royal Society of Medicine on Saturday 16 April to take part in the Society’s 12th Medical Innovations Summit. Providing a twice-yearly platform for the presentation and discussion of inspirational ideas and developments in the field of medicine and healthcare, the Summits encourage innovators at the very beginning of their careers, as well as established clinicians and academics.

4 Apr 2016

New test can detect early stages of sight loss in age-related macular degeneration

Researchers based at the National Institute for Health Research (NIHR) Biomedical Research Centre (BRC) at Moorfields Eye Hospital and UCL Institute of Ophthalmology, received funding from Fight for Sight and the Special Trustees of Moorfields Eye Hospital NHS Foundation Trust which has resulted in the design of a new test that can spot the first stages of sight loss in age-related macular degeneration (AMD).

30 Mar 2016

Researchers provide new mechanism for age-related macular degeneration

Age-related macular degeneration (AMD) is the leading cause of visual impairment in people over 50 in developed countries. Although this condition affects up to 20% of people between the ages of 65 and 75, what drives abnormal blood vessels to invade the retina is unknown.

15 Mar 2016

Macular Degeneration News and Research

Latest Macular Degeneration News and Research

Buck researchers identify new, potential drug targets for sporadic PD

Small drug-like molecule that alters perception of food may hold key to extending human healthspan

Vision Express advises Britons to be 'sun safe' when choosing eyewear

NIH-funded study finds visual impairment, blindness may double by 2050

LALES study analyzes risk, prevalence of early and late stage AMD among Latinos

Report: Protecting eyes from UV exposure not high priority for Americans

Researchers safely transplant stem cells from patient's skin to the eye to restore vision

Artificial and natural vision successfully integrated for first time in humans

NEI-funded study analyzes outcomes of anti-VEGF therapy for AMD

NEI to discuss research advances in regenerative medicine for eye disease at ARVO 2016

Scientists find way to reduce need for secondary cataract surgery

Pioneering gene therapy may lead to potential cure for common causes of vision loss

Exposure to blue light may lead to eyestrain but does not damage retina

University’s blindness therapy comes a step closer following landmark licensing deal with US firm

University's blindness therapy comes a step closer following landmark licensing deal with US firm

Increased expression of VEGF-A promotes three common aging-related eye conditions

Daily walnut consumption positively impacts blood cholesterol levels in older adults

Leading entrepreneurs, innovators to take part in Royal Society of Medicine's 12th Medical Innovations Summit

New test can detect early stages of sight loss in age-related macular degeneration

Researchers provide new mechanism for age-related macular degeneration

Innovation in neuroscience drug discovery - eBook eBook

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Reimagining light scattering for biotherapeutics

Empowering genomics research with cloud-based innovation

Macular Degeneration News and Research

Latest Macular Degeneration News and Research

Innovation in neuroscience drug discovery - eBook eBook

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Reimagining light scattering for biotherapeutics

Empowering genomics research with cloud-based innovation

Newsletters you may be interested in